John T. Philbrick, MD; Steven Heim, MD, MSPH; Joel M. Schectman, MD, MPH
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Philbrick J., Heim S., Schectman J.; d-Dimer and Venous Thromboembolism. Ann Intern Med. 2004;141:482. doi: 10.7326/0003-4819-141-6-200409210-00020
Download citation file:
Published: Ann Intern Med. 2004;141(6):482.
TO THE EDITOR:
Although Stein and colleagues' conclusion, “a negative quantitative rapid ELISA result is as diagnostically useful as a normal lung scan or negative duplex ultrasonography finding,” is technically correct (1), the issues surrounding this use of d-dimer are more complex. For a test used to rule out disease, high sensitivity is not the only important characteristic. Specificity also plays a key role and limits the use of d-dimer for venous thromboembolism (VTE) in at least 2 ways.
First, the likelihood ratio for a negative test result, calculated as (1 − sensitivity)/specificity, is inversely proportional to specificity. Few tests have invariable sensitivity and specificity. Instead, these indexes vary with the clinical characteristics of patient samples. This is particularly true for the specificity of d-dimer. Many conditions besides thromboembolism cause “elevated” d-dimer levels. When large numbers of patients with these conditions, such as cancer, trauma, surgery, and advanced age, are included in a study, specificity will be very low, the likelihood ratio for a negative test result will not be as small as reported by Stein and colleagues (1), and d-dimer levels of those with VTE will sometimes be indistinguishable from levels in those without (2). Thus, unless the clinician orders d-dimer testing only in patients without conditions known to cause elevated levels, results will not be diagnostically useful for VTE.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only